Rapid Weight Loss From GLP-1 Injections Fuels Surge in Facial Fat Grafting Demand
Demand for facial fat grafting procedures that uses a person’s own body fat to restore lost facial volume is…
-
-
Semaglutide Sustains Reduced Calorie Intake Beyond One Year
Even when people start feeling hungry again, semaglutide helps them eat fewer calories for over a year. A study…
-
GLP-1 Use Among Americans Reaches New Peak
Recent polling data indicates that patient utilization of GLP-1 medications has reached its highest historical level. Eleven percent of…
-
Medicare Launches Temporary GLP-1 Bridge Program Amid New Evidence on Weight Loss Drugs in Older Adults
The Centers for Medicare and Medicaid Services just started a temporary program this week. This new project gives older…
-
CVS Pharmacy Expands GLP-1 Support to Improve Access and Treatment Continuity
CVS Health has announced a broader plan to support patients on GLP-1 receptor agonist therapy across its retail pharmacy…
-
Monthly GLP-1 Injections Move Closer to Clinical Reality as Pfizer and Amgen Advance Trials
The main method in GLP-1 treatment focuses on weekly subcutaneous injections. This schedule balances the drug’s half-life with what…
-
How Weight Loss Injections Can Help Silence Food Noise
Many people face constant thoughts about eating throughout the day. Doctors call this experience food noise. These thoughts often…
-
GLP-1 Maintenance Dosing: Clinical Evidence for Sustained Weight Management
Obesity treatment utilising GLP-1 receptor agonists yields substantial weight loss outcomes. However, discontinuing these pharmacological agents often leads to…
-
The GLP-1 Injection Challenge: Managing Shortages and Compounding Options
Drugs like Ozempic, Wegovy, and Mounjaro have completely changed how we treat obesity and type 2 diabetes. Because they…
-
Understanding Dose Strength Differences Between Foundayo and Zepbound
The federal approval of Foundayo on April 1, 2026, marks a major change in obesity care. This medication is…
